These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36727060)

  • 1. Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases.
    Uder L; Nachbar M; Butzer S; Boldt J; Baumeister S; Bitzer M; Königsrainer A; Seufferlein T; Hoffmann R; Gatidis S; Nikolaou K; Zips D; Thorwarth D; Gani C; Boeke S
    Front Oncol; 2022; 12():1095633. PubMed ID: 36727060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.
    Gani C; Boeke S; McNair H; Ehlers J; Nachbar M; Mönnich D; Stolte A; Boldt J; Marks C; Winter J; Künzel LA; Gatidis S; Bitzer M; Thorwarth D; Zips D
    Clin Transl Radiat Oncol; 2021 Jan; 26():55-61. PubMed ID: 33319073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study.
    Bordeau K; Michalet M; Keskes A; Valdenaire S; Debuire P; Cantaloube M; Cabaillé M; Jacot W; Draghici R; Demontoy S; Quantin X; Ychou M; Assenat E; Mazard T; Gauthier L; Dupuy M; Guiu B; Bourgier C; Aillères N; Fenoglietto P; Azria D; Riou O
    J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
    Weykamp F; Hoegen P; Regnery S; Katsigiannopulos E; Renkamp CK; Lang K; König L; Sandrini E; Meixner E; Rippke C; Buchele C; Liermann J; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.
    Weykamp F; Hoegen P; Klüter S; Spindeldreier CK; König L; Seidensaal K; Regnery S; Liermann J; Rippke C; Koerber SA; Buchele C; Debus J; Hörner-Rieber J
    Front Oncol; 2021; 11():610637. PubMed ID: 34178616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution.
    Hoegen-Saßmannshausen P; Jessen I; Buchele C; Schlüter F; Rippke C; Renkamp CK; Weykamp F; Regnery S; Liermann J; Meixner E; Hoeltgen L; Eichkorn T; König L; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
    Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
    Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
    Eijkelenkamp H; Grimbergen G; Daamen LA; Heerkens HD; van de Ven S; Mook S; Meijer GJ; Molenaar IQ; van Santvoort HC; Paulson E; Erickson BA; Verkooijen HM; Hall WA; Intven MPW
    Front Oncol; 2023; 13():1040673. PubMed ID: 37854684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours.
    Hering S; Nieto A; Marschner S; Hofmaier J; Schmidt-Hegemann NS; da Silva Mendes V; Landry G; Niyazi M; Manapov F; Belka C; Corradini S; Eze C
    Clin Transl Radiat Oncol; 2024 Mar; 45():100736. PubMed ID: 38433949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases.
    Ugurluer G; Schneiders FL; Corradini S; Boldrini L; Kotecha R; Kelly P; Portelance L; Camilleri P; Ben-David MA; Poiset S; Marschner SN; Panza G; Kutuk T; Palacios MA; Castelluccia A; Zoto Mustafayev T; Atalar B; Senan S; Ozyar E
    Clin Transl Radiat Oncol; 2024 May; 46():100756. PubMed ID: 38450219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
    Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma.
    Poiset SJ; Shah S; Cappelli L; Anné P; Mooney KE; Werner-Wasik M; Laufer TS; Posey JA; Lin D; Basu Mallick A; Lavu H; Bashir B; Yeo CJ; Mueller AC
    Radiat Oncol; 2024 May; 19(1):65. PubMed ID: 38812040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes.
    Weykamp F; Herder-Wagner C; Regnery S; Hoegen P; Renkamp CK; Liermann J; Rippke C; Koerber SA; König L; Buchele C; Klüter S; Debus J; Hörner-Rieber J
    Strahlenther Onkol; 2022 Jan; 198(1):56-65. PubMed ID: 34468783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.
    Anstadt EJ; Shumway R; Colasanto J; Grew D
    J Gastrointest Oncol; 2019 Apr; 10(2):330-338. PubMed ID: 31032102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter
    Fink CA; Ristau J; Buchele C; Klüter S; Liermann J; Hoegen-Saßmannshausen P; Sandrini E; Lentz-Hommertgen A; Baumann L; Andratschke N; Baumgartl M; Li M; Reiner M; Corradini S; Hörner-Rieber J; Bonekamp D; Schlemmer HP; Belka C; Guckenberger M; Debus J; Koerber SA
    Clin Transl Radiat Oncol; 2024 May; 46():100771. PubMed ID: 38586081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
    Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
    Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
    Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
    Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: First Reported Clinical Outcomes From the UK.
    Nugent K; Mukherjee S; Teoh S; George B; Martin A; Gaya A; Aznar-Garcia L; Chu K; Robinson M; Maughan T; Good J
    Clin Oncol (R Coll Radiol); 2024 Sep; 36(9):576-584. PubMed ID: 38902119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.